See every side of every news story
Get Started
SubscribeLogin
SAG Awards
Olaf Scholz
Israel-Hamas Conflict
Military
Ukraine War
Hamas
Wrestling
Donald Trump
Elon Musk
Basketball
US Politics
Pope Francis
Published • loading... • Updated

Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels

Summary by diagnosticimaging.com
18F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
diagnosticimaging.comdiagnosticimaging.com

Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels

18F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

diagnosticimaging.com broke the news in on Thursday, February 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

United States

United States

News
For You
Search
BlindspotLocal